PSMA PET-Positive Castration-Resistant Prostate Cancer
3 clinical trials · Condition
◉ Watch PSMA PET-Positive Castration-Resistant Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) (NCT06549465) | Convergent Therapeutics | 2024-08-06 |
| Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer (NCT06809426) | Affiliated Hospital of Jiangnan University | 2023-08-21 |
| Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer (NCT06850545) | Kuopio University Hospital | 2020-01-10 |
Track PSMA PET-Positive Castration-Resistant Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.